Invention Grant
- Patent Title: Quinazoline derivatives and their use as DNA methyltransferase inhibitors
-
Application No.: US15023209Application Date: 2014-09-19
-
Publication No.: US09951044B2Publication Date: 2018-04-24
- Inventor: Ludovic Halby , Paola Barbara Arimondo
- Applicant: PIERRE FABRE MEDICAMENT , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Applicant Address: FR Boulogne-Billancourt FR Paris
- Assignee: PIERRE FABRE MEDICAMENT,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee: PIERRE FABRE MEDICAMENT,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee Address: FR Boulogne-Billancourt FR Paris
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: EP13306281 20130919
- International Application: PCT/EP2014/070011 WO 20140919
- International Announcement: WO2015/040169 WO 20150326
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D401/14 ; A61K31/517
Abstract:
The present invention relates to compounds of the following formula (I): and pharmaceutically acceptable salts and solvates thereof, their methods of preparation, their use as a drug, notably in the treatment of cancer, and pharmaceutical compositions containing such compounds.
Public/Granted literature
- US20160229834A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS DNA METHYLTRANSFERASE INHIBITORS Public/Granted day:2016-08-11
Information query
